Nuclear Fusion Reactor for Medical Isotopes and Materials Testing

This is nuclear fusion.

Over the last four years, we've been quietly building the

foundational technologies

for fusion in downtown San Francisco, and now we're bringing it all together in

our

first reactor, which we're making available to our first

partners in twenty

twenty-seven for medical isotope production and materials qualification.

First, we melt lithium and evaporate it onto a solid plate.

This layer of lithium can be saturated with hydrogen isotopes

and used as a target.

Then we ionize deuterium and accelerate those ions through an

electric field into

the target, creating fusion.

Using this simple architecture, we can scale at an unprecedented rate,

doubling

the fusion power density that we get every month over the next

year.

We chose this architecture because it works.

In the 1980s, scientists at Lawrence Livermore National

Lab operated a similar

reactor for over twenty-five thousand hours at high fusion power density.

Why revisit this? Because demand for radiopharmaceuticals

has gone

exponential, with the most successful treatments

serving tens of thousands of

patients per year.

Our first generation of commercial reactors will transform fusion from an

experiment to an industry, developing critical supply chains

and allowing us

to test the materials necessary for operation of fusion power plants.

And that's just the start. Fertilizers to feed half of humanity,

semiconductors, and most of our modern medicines came from

the ability to

design molecules. And now we're going a step further,

kicking off a

revolution in scalable transmutation.

Our recent experiments have shown production of rare medical isotopes,

of tritium

to power fusion reactors, and even validated our scalable pathway

for

co-production of electricity and gold.

This is nuclear fusion for medicine, for materials, and

for energy.